Related Experiment Video
Updated: Apr 29, 2026

Preparation of Pooled Human Platelet Lysate pHPL as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
Published on: October 30, 2009
Lyophilized human platelet lysate: manufacturing, quality control, and application
Kerstin Wendland1,2, Lea Koblin1,2, Dirk Stobbe2
1Institute of Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.
Lyophilized human platelet lysate (L-HPL) maintains quality and functionality comparable to standard HPL, offering a stable and ethical cell culture supplement. This process enhances the utility of HPL for biomedical research and cell therapy production.
Area of Science:
- Biotechnology
- Cell Biology
- Regenerative Medicine
Background:
- Platelet concentrates (PCs) are often discarded due to short shelf life, leading to waste.
- Human platelet lysate (HPL) from expired PCs is a promising, ethical alternative to animal serum in cell culture.
- Current HPL use is limited by batch variability and poor storage stability.
Purpose of the Study:
- To develop a lyophilization protocol for HPL to improve its stability and applicability.
- To evaluate the impact of lyophilization on HPL's quality control parameters and growth factor content.
- To assess the functionality of lyophilized HPL (L-HPL) in supporting human mesenchymal stromal cell (hMSC) culture and differentiation.
Main Methods:
- Paired comparison of six HPL and L-HPL batches for pH, protein, osmolality, and electrolyte concentrations.
- Quantification of 11 growth factors and cytokines in HPL versus L-HPL.
- Assessment of hMSC yield, proliferation, viability, and trilineage differentiation potential in media supplemented with HPL or L-HPL.
Main Results:
- L-HPL showed comparable pH, osmolality, and potassium levels to HPL, with slightly lower total protein, sodium, and chloride.
- Growth factor and cytokine concentrations were consistent between HPL and L-HPL.
- hMSCs cultured with L-HPL exhibited similar cell yield, division cycles, and viability compared to those cultured with HPL.
- Osteogenic differentiation capacity was slightly enhanced in cells cultured with L-HPL, while adipogenic and chondrogenic potentials remained unchanged.
Conclusions:
- A robust protocol for producing stable, applicable L-HPL was successfully established.
- L-HPL demonstrates comparable quality control parameters, growth factor profiles, and hMSC functionality to standard HPL.
- L-HPL serves as a suitable, stable, and ethical cell culture supplement, offering a viable alternative to animal-derived sera in research and therapeutic applications.
More Related Videos
10:32Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020